EN DE

Crookes Brothers Ltd (CKS) Fair Value & Analysis

Consumer Defensive · ZA · Market cap 303M ZAC · ISIN ZAE000001434

What is Crookes Brothers Ltd really worth?

CB Crookes Brothers Ltd CKS · JSE
PriceR19.50
Fair ValueR47.15
Upside+141.8%
Quality35/100

Below-average quality, trading 59% below our fair value of R47.15.

Watch Crookes Brothers Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Risks

!Expensive Growth (revenue 5y +4.1 %/yr)
!Loss-making · -36.7% net margin
!Low debt · negative free cash flow
!Trails peers (4/11)
!Narrow moat 8/100
!Evidence only medium, so the estimate is less certain

For context

·7.69% dividend yield
Evidence: Medium Range R29.18 – R47.15

Fair value as of: Aug 13, 2026

From 6 valuation models · updated 18 days ago

Share price −2.7% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The large discount to fair value meets weak quality (35/100). That raises the risk this is a value trap rather than a bargain.
  • The price is below even our cautious bear case (R29.18). The market is more pessimistic than our downside scenario.

Price vs Fair Value (5 years)

R44.98 R17.00 Fair Value R47.15 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range R17.00 – R44.98 · fair‑value band R29.18 – R47.15 · the R19.50 price screens below the R47.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Crookes Brothers Ltd (CKS) currently trades at R19.50, while our model-based Fair Value estimate is R47.15, implying the stock looks roughly 58.6% undervalued today. The Quality Score stands at 35/100 (below-average quality), in the Consumer Defensive sector. Bull case: the Asset-Based group reads highest at a median of R32.83 per share, and 4 of the 6 models we run sit above the R19.50 price. Bear case: the Earnings-Based group reads lowest at R17.20, and 2 of the 6 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Crookes Brothers Ltd generated revenue of 807M ZAR at a net margin of 6.2%. Revenue declined 5.2% year over year. It earns a return on equity of 5.4%. Net debt stands at 374M ZAR. Fundamentals as of Aug 13, 2026

Our scenario range runs from R29.18 (bear case) to R47.15 (bull case); at R19.50, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Consumer Defensive peers we cover trades at −19% fair-value upside, at 142%, CKS screens cheaper than that median.

Fair Value models

This estimate rests on fiscal year 2026 figures, and about 5 months have passed since. In that time the company retained roughly 0.7426 ZAR per share, which is 1.6 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
EPV best evidence R15.60 R17.20 R18.54 74
ROIC Compounder R15.60 R17.20 R18.54 72
EV/EBITDA R57.77 R75.74 R93.72 67
All 6 models by family
Earnings-Based
EPV best evidence R15.60 R17.20 R18.54 74
Multiples
EV/EBIT R24.65 R31.58 R38.52 66
EV/EBITDA R57.77 R75.74 R93.72 67
EV/Revenue R18.70 R25.06 R31.42 54
Asset-Based
NCAV (Graham) R24.50 R32.83 R49.00 54
Economic Profit
ROIC Compounder R15.60 R17.20 R18.54 72

Widest divergence: Asset-Based (R32.83) versus Earnings-Based (R17.20). Highest evidence: EPV (74).

Notify me when CKS reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 6.2 as of Jul 17, 2026
P/S ratio 0.39 TTM
EPS (TTM) R−18.69 price ÷ EPS = P/E 6.2
Dividend yield 7.7%
Net margin −36.7% FY2026
Return on equity −28.5% TTM
More key figures
Profitability
Return on assets (EBIT) 2.0% avg 5y
Operating margin −13.7% TTM
Growth
Revenue (TTM) 778M ZAR TTM
Revenue growth (YoY) −9.3% 3y avg +8.1%
EPS growth (YoY) −48.2%
Balance sheet & cash flow
Free cash flow −13.6M ZAC FY2026
Net debt 374M ZAC FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 35/100

Of which business quality 35 · Market factors (momentum, volatility) 32

Profitability 8
Margins and returns on capital today
Quality Growth 11
Are margins and returns improving?
Cashflow 16
Earnings quality: real cash, not paper profit
Fin. Strength 38
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 60
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 6
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Crookes Brothers Limited, an investment holding company, engages in the agricultural business in South Africa, Eswatini, Zambia, and Mozambique. The company grows sugar cane, bananas, and macadamia nuts. It is also involved in the development and sale of industrial, commercial, and residential property, as well as leases building.

Full company description

Crookes Brothers Limited, an investment holding company, engages in the agricultural business in South Africa, Eswatini, Zambia, and Mozambique. The company grows sugar cane, bananas, and macadamia nuts. It is also involved in the development and sale of industrial, commercial, and residential property, as well as leases building. In addition, the company engages in tourism business, as well as provision of utility services related to the property development. The company was founded in 1860 and is headquartered in Umhlanga, South Africa.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Crookes Brothers Ltd reported revenue of 778M ZAR in FY2026 versus 679M ZAR in FY2022, a compound +3.5%/yr. Reported net income was −285M ZAR in FY2026.

Growth Quality 29/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
778M ZAR
Latest YoY
−6.7%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.1%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.1%
Avg. revenue growth/yr (23Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.6%
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed
Revenue +3.5%/yr
FY22 679M ZAR
FY23 616M ZAR
FY24 728M ZAR
FY25 834M ZAR
FY26 778M ZAR
Net income
FY22 62.6M ZAR
FY23 −196M ZAR
FY24 61.3M ZAR
FY25 68.1M ZAR
FY26 −285M ZAR
Character of growth · EPS growth decomposed (2015-2026) +0.8 % p.a.
Revenue per share +2.5 %

of which total revenue +3.6 % · buybacks/dilution −1.1 %

EBIT margin −0.1 %
Tax rate +0.4 %
Residual (interest, one-offs) −1.9 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

Watch CKS: get an alert when its fair value changes →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Crookes Brothers Ltd Fair Value". https://www.fairvalue-calculator.com/stock/CKS

Peer Group

Farm Products · 299 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 35 · Bottom 25%
Fair Value upside +142% · Top 25%
Return on assets 0% · Below median
Net margin (TTM) −37% · Bottom 25%
Operating margin (TTM) −14% · Bottom 25%
Revenue growth −9% · Bottom 25%
Dividend yield (TTM) 7.7% · Top 25%
Debt / equity 0.15× · Higher than median

Valuation Multiples vs Farm Products median · lower = cheaper

P/E (TTM) 6.2× · Cheaper than 75% of peers
P/S (TTM) 0.02× · Cheaper than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE100 · sector 25
FUTURE0 · sector 21
PAST0 · sector 19
HEALTH93 · sector 94
DIVIDEND100 · sector 49

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $81.54 $38.02 −53%
Muyuan Foods Group 002714 ¥40.15 ¥47.42 +18%
Bunge Global SA BG $111.57 $56.19 −50%
Tyson Foods, Inc TSN $55.40 $28.60 −48%
Wens Foodstuff Group 300498 ¥13.80 ¥11.18 −19%
Mowi ASA MOWI kr 206.00 kr 260.70 +27%
Fujian Wanchen Food Group 300972 ¥201.06 ¥143.09 −29%
United Plantations Berhad 2089 32.60 MYR 23.34 MYR −28%
PT Charoen Pokphand Indonesia Tbk, CPIN 2,960 IDR 6,818 IDR +130%
Charoen Pokphand Foods Public Company CPF 23.40 THB 43.24 THB +85%

Compare Crookes Brothers Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Fama-French 3-Factor Model Calculator Run the Fama-French 3-factor model in seconds: expected return from the market, size and value factors - free, with formula, betas and an example. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Crookes Brothers Ltd (CKS) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of R47.15 versus a price of R19.50, about +142% upside (undervalued).
What is the fair value of CKS?
Our model-based fair value for Crookes Brothers Ltd is R47.15 (as of Aug 13, 2026), built from audited fundamentals. The current price: R19.50.
What is the quality score of CKS?
Crookes Brothers Ltd has a Quality Score of 35/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Crookes Brothers Ltd (CKS)?
Crookes Brothers Ltd reported trailing-twelve-month revenue of about 807M ZAR (latest available figure, as of Aug 13, 2026).
What is the net profit margin of CKS?
The net profit margin of Crookes Brothers Ltd is about 6.2%, meaning it keeps roughly 6.2% of revenue as net income. Based on the latest reported figures.
Does Crookes Brothers Ltd pay a dividend?
Crookes Brothers Ltd currently shows a dividend yield of about 7.69% relative to its recent price (as of Aug 13, 2026).
Free · no account needed

Watch Crookes Brothers Ltd in the live analysis

One click puts Crookes Brothers Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.